Daniel Carbajo

Daniel Carbajo

Auto-generated profile, based on publicly available information

Daniel Carbajo

ImmunoScape Pte Ltd , Singapore 228208

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
HKHassen Kared
Hassen Kared
ARAndrew D. Redd
Andrew D. Redd
EBEvan M. Bloch
Evan M. Bloch
TBTania S. Bonny
Tania S. Bonny
HSHermi Sumatoh
Hermi Sumatoh
TQThomas C. Quinn
Thomas C. Quinn
Characterization of the T cell response in individuals who recover from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is critical to understanding its contribution to protective immunity. A multiplexed peptide-MHC tetramer approach was used to screen 408 SARS-CoV-2 candidate epitopes for CD8+ T cell recognition in a cross-sectional sample of 30 coronavirus disease 2019 convalescent individuals. T cells were evaluated using a 28-marker phenotypic panel, and findings were modelled against time from diagnosis and from humoral and inflammatory responses. There were 132 SARS-CoV-2–specific CD8+ T cell responses detected across 6 different HLAs, corresponding to 52 unique epitope reactivities. CD8+ T cell responses were detected in almost all convalescent individuals and were directed against several structural and nonstructural target epitopes from the entire SARS-CoV-2 proteome. A unique phenotype for SARS-CoV-2–specific T cells was observed that was distinct from other common virus-specific T cells detected in the same cross-sectional sample and characterized by early differentiation kinetics. Modelling demonstrated a coordinated and dynamic immune response characterized by a decrease in inflammation, increase in neutralizing antibody titer, and differentiation of a specific CD8+ T cell response. Overall, T cells exhibited distinct differentiation into stem cell and transitional memory states (subsets), which may be key to developing durable protection.

8 October 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
HKHassen Kared
Hassen Kared
ARAndrew D Redd
Andrew D Redd
EBEvan M. Bloch
Evan M. Bloch
TBTania S. Bonny
Tania S. Bonny
HSHermi Sumatoh
Hermi Sumatoh
TQThomas C Quinn
Thomas C Quinn
Characterization of the T cell response in individuals who recover from SARS-CoV-2 infection is critical to understanding its contribution to protective immunity. A multiplexed peptide-MHC tetramer approach was used to screen 408 SARS-CoV-2 candidate epitopes for CD8+ T cell recognition in a cross-sectional sample of 30 COVID-19 convalescent individuals. T cells were evaluated using a 28-marker phenotypic panel, and findings were modelled against time from diagnosis, humoral and inflammatory responses. 132 distinct SARS-CoV-2-specific CD8+ T cell epitope responses across six different HLAs were detected, corresponding to 52 unique reactivities. T cell responses were directed against several structural and non-structural virus proteins. Modelling demonstrated a coordinated and dynamic immune response characterized by a decrease in inflammation, increase in neutralizing antibody titer, and differentiation of a specific CD8+ T cell response. Overall, T cells exhibited distinct differentiation into stem-cell and transitional memory states, subsets, which may be key to developing durable protection.

26 December 2024 in Bioinformatics Advances
Verified
Journal Article
Open access
FSFlorian Schmidt
Florian Schmidt
KWKanxing Wu
Kanxing Wu
LGLorenz Gerber
Lorenz Gerber
FJFlorence Chioh Wen Jing
Florence Chioh Wen Jing
DCDaniel Carbajo
Daniel Carbajo
AWAndreas Wilm
Andreas Wilm
Summary: The exogenous, i.e. in vitro, loading of peptides onto major histocompatibility complex (MHC) class I molecules is a key step in many immunology-related experimental workflows. Here, we provide a machine learning solution, PIPLOM, which is specifically tailored to predict whether peptides can be loaded exogenously onto an MHC class I molecule. Benchmarking on 38 unseen epitopes with in-house ELISA (enzyme-linked immunosorbent assay) experiments showed that PIPLOM is outperforming well-established methods such as NETMHCpan-4.0 or MHCflurry, which are commonly used for the related task of predicting epitope HLA (human leukocyte antigen) haplotype specificity. Availability and implementation: Source code and data are available as Zenodo package 10.5281/zenodo.13771214. PIPLOM is available as a web service at https://piplom.immunoscape.com/.